[Lecture Report] The 2nd Nikkei Super Active Ageing Society Conference – The 2nd International Conference Aiming to Resolve the Issues of Ageing (November 16, 2020)
date : 12/2/2020
Health and Global Policy Institute (HGPI) Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake participated in the summary session of the 2nd Nikkei Super Active Ageing Society Conference, which was entitled, “The 2nd International Conference Aiming to Resolve the Issues of Ageing.” During the session, Dr. Kurokawa participated as a panelist and Mr. Noritake served as moderator.
During the discussion, Dr. Kurokawa said that the world is paying close attention to Japan, where population aging has advanced the most, and that means it is important to share information on the current circumstances surrounding population aging in Japan and efforts being made to respond to it. Dr. Kurokawa also pointed out the importance of having a clear division of roles between science and governance in times of emergency, such as during pandemics or after large-scale natural disasters, and that it is imperative for Japan to make improvements in that regard. Finally, to promote the future development of international society, Dr. Kurokawa stressed that it is urgent for Japan to produce the human resources needed to provide global leadership.
Mr. Noritake provided a summary of the lectures and panel discussions held that day. He also spoke on the importance of discussion, saying, “COVID-19 showed us Japan’s weaknesses. It is important to have discussions on the effective use of technology, including digital technology, and that generate short, medium, and long-term perspectives.” The ideal format for future conferences was also explored during the summary session.
For more details, please see the event website here.
HGPI also participated in the planning of this conference.
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Closed] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-24
[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)